What is Gastrointestinal Neuroendocrine Tumors ?

Gastrointestinal neuroendocrine tumors (GI NETs) are uncommon tumors that arise from specialized neuroendocrine cells lining the gastrointestinal (GI) tract. The cells in question exhibit traits characteristic of nerve and endocrine cells, which produce hormones. The cells release hormones that control digestive processes, including gut motility, enzyme secretion, and blood flow to the digestive system.

Neuroendocrine tumors can develop anywhere in the GI tract, including the stomach, small intestine, appendix, colon, and rectum. The tumors generally exhibit slow growth rates, yet a subset of tumors exhibits aggressive behavior, which leads to metastasis in distant organs with a preference for the liver.

The tumors produce hormones that enter the bloodstream and induce specific hormonal syndromes in some patients. The discovery of GI NETs occurs during imaging or endoscopic examinations conducted to investigate various medical conditions.

The diagnosis process involves early diagnosis and appropriate staging of the tumor, after which treatment is decided based on whether surgery, medication, targeted therapy, or systemic treatment is needed, depending on tumor grade and stage.

What are the Symptoms & Causes of Gastrointestinal Neuroendocrine Tumors?

Symptoms of Gastrointestinal Neuroendocrine Tumors

The symptoms of the disease depend on where the tumor is situated, how large it has grown, and whether it produces hormones.

Non-functioning tumors (do not produce hormones)

The symptoms occur because of pressure from the growing mass, which results in the following conditions:

• Abdominal pain
• Bloating
• Intestinal obstruction
• Gastrointestinal bleeding
• Anemia
• Changes in bowel habits
• Unexplained weight loss

Functioning tumors (produce hormones)

The hormone-producing tumors lead to the development of various symptoms, which include:

• Flushing of the face and neck
• Chronic diarrhea
• Wheezing
• Rapid heartbeat
• Abdominal cramping

The symptoms appear when tumor-secreted substances, including serotonin, enter the systemic circulation after liver metastasis occurs, which leads to the development of carcinoid syndrome.

What are the Risk Factors of Gastrointestinal Neuroendocrine Tumors ?

While the precise causes of GI NETs remain unknown, several inherited genetic disorders predispose to the development of such tumors, such as:

• Multiple endocrine neoplasia type 1 (MEN1)
• Neurofibromatosis type 1
• Von Hippel-Lindau-Syndrom

Most GI NETs occur sporadically without a clear hereditary link.

The following factors might lead to GI NET development:

• Chronic atrophic gastritis
• Long-standing acid suppression therapy (for gastric NETs)
• Smoking (in some studies)

The development of many gastrointestinal cancers relies primarily on dietary choices and habitual smoking, yet this relationship does not hold true for all types of digestive system cancers.

What are the different Types of Gastrointestinal Neuroendocrine Tumors?

GI NETs use two criteria, which are location and grade, to categorize their tumors.

Based on Location:

• Gastric NETs (stomach)
• Small intestinal NETs (most common)
• Appendiceal NETs
• Colonic NETs
• Rectal NETs

Based on Tumor Grade:

Tumor grade reflects how fast the tumor is likely to grow.

• Grade 1 (low grade) - Slow-growing
• Grade 2 (intermediate grade)
• Grade 3 (high-grade neuroendocrine carcinoma) - Aggressive

Tumor grade is determined by assessing mitotic rate and Ki-67 proliferation index during pathological examination.

How are Gastrointestinal Neuroendocrine Tumors Diagnosed and Tested?

Accurate diagnosis extends beyond imaging because it requires laboratory testing and biopsy results.

Clinical Evaluation

The doctors conduct a complete history and physical examination. The presence of symptoms, which include flushing and chronic diarrhea, creates suspicion.

Blood & Urine Tests

The tests may include:

• Serum chromogranin A
• 24-hour urinary 5-HIAA (for serotonin-producing tumors)
• Liver function tests

The diagnostic process uses these markers to confirm the presence of disease, while they also enable doctors to observe the effectiveness of treatment.

Imaging Studies

• CT Scan with contrast.
• MRI (especially useful for liver metastasis)
• Somatostatin Receptor Imaging (Ga-68 DOTATATE PET-CT)
• Standard PET-CT (in cases of high-grade tumors)

It is useful in Somatostatin Receptor Imaging because NETs usually express somatostatin receptors.

Endoscopy

Direct visualization, together with biopsy collection of gastric, small intestinal, or colorectal NETs, is performed during endoscopic procedures.

Biopsy

The process of definite diagnosis requires histopathological evaluation, which includes:

• Tumor differentiation
• Grade
• Ki-67 index
• Immunohistochemistry markers

The information obtained from this process determines which treatment path to take.

What are the Stages of Gastrointestinal Neuroendocrine Tumors?

Staging for the disease requires the assessment of:

• Tumor size
• Depth of invasion
• Lymph node involvement
• Distant metastasis

The TNM staging system is used.

The following locations serve as frequent sites for tumor metastasis:

• Liver (most common)
• Lymph nodes
• Bone
• Peritoneum

What are the Treatment and Management Options for Gastrointestinal Neuroendocrine Tumors?

Tumor characteristics determine the selected treatment method, which depends on its location, grade, size, and extent of spread.

Surgery

Localized diseases require surgical intervention as the primary treatment.

The procedures differ depending on the specific area:

• Endoscopic removal for small gastric or rectal NETs
• Segmental bowel resection for small intestinal tumors
• Appendectomy for small appendiceal NETs
• Colectomy for colonic NETs

Surgical elimination is the best way to cure in early-stage disease.

Management of Liver Metastases

When cancer spreads to the liver, medical professionals use three treatment options, which include:

• Surgical resection
• Radiofrequency ablation
• Transarterial embolization (TAE)
• Transarterial chemoembolization (TACE)

Selected patients benefit from aggressive management of liver disease.

Somatostatin Analog Therapy

The medications octreotide and lanreotide produce two main effects:

• They stop hormone-related symptoms from occurring.
• They prevent tumor growth from continuing.

The drugs in this treatment system bind to somatostatin receptors on cancer cells.

Targeted Therapy

The treatment of advanced disease relies on these two drugs:

• Everolimus (mTOR inhibitor)
• Sunitinib (in select cases)

The two medications help minimize tumor growth.

Peptide Receptor Radionuclide Therapy (PRRT)

PRRT uses radio-labeled somatostatin analogs to deliver radiation to tumor cells. The treatment shows strong efficacy against metastatic well-differentiated NETs, as demonstrated by positive somatostatin receptor imaging results.

Chemotherapy

Chemotherapy exclusively treats two patient groups:

• Patients with high-grade neuroendocrine carcinomas
• Patients with high-speed disease advancement

The treatment schedule requires the use of platinum-containing drugs in multiple treatment combinations.

What are the Complications associated with Gastrointestinal Neuroendocrine Tumors?

Patients experience two kinds of complications, which result from tumor development and excess hormone secretion.

The list of possible complications includes:

• Intestinal obstruction
• Carcinoid heart disease
• Liver failure (in extensive metastasis)
• Malnutrition
• Hormonal crisis during surgery (carcinoid crisis)

Surgeons achieve better results when they conduct thorough planning work before surgical operations.

What is the Outlook / Prognosis of Gastrointestinal Neuroendocrine Tumors ?

Medical outcomes depend on these three factors:

• Tumor grade
• Stage at diagnosis
• Location
• Completeness of surgical removal

Patients with low-grade tumors that remain localized usually achieve favorable outcomes throughout their lives. Patients with high-grade neuroendocrine carcinomas require systemic therapy because their disease shows more aggressive symptoms.

Patients with well-differentiated NETs can expect to live many years with appropriate treatment and medical follow-up.

What is the Follow-Up Care for Gastrointestinal Neuroendocrine Tumors?

Patients need monitoring through these three processes:

• Periodic imaging tests
• Tumor marker testing
• Assessment of clinical symptoms

NETs exhibit slow growth, leading to extended periods of medical observation.

Supportive & Multidisciplinary Care

Medical treatment requires various medical specialists to work together:

• Surgical oncology
• Medical oncology
• Gastroenterology
• Endocrinology
• Interventional radiology

To achieve the best possible quality of life, patients require nutritional counseling in addition to symptom management.

Why choose Tender Palm Super-Speciality Hospital for Gastrointestinal Neuroendocrine Tumor Treatment in Lucknow, India?

Tender Palm Super-Speciality Hospital offers advanced Gastrointestinal Neuroendocrine Tumors treatment in Lucknow, India, at an affordable cost. We have a team of experienced gastrointestinal surgeons and oncology specialists who provide accurate diagnosis and both non-surgical and surgical treatment options including surgical resection, somatostatin analogue therapy, and targeted therapy. Our Gastrointestinal Surgery and Oncology team has decades of experience in successfully treating Gastrointestinal Neuroendocrine Tumors in Lucknow, India.

To seek an Expert consultation for Gastrointestinal Neuroendocrine Tumor Treatment in Lucknow, India:

Call us at +91-9076972161
Email at care@tenderpalm.com

Request a Call Back